Furthermore, expression of the checkpoint inhibitor programmed cell death ligand 1 (PD-L1) in TNBCs is primarily found on tumor-infiltrating immune cells and is correlated with longer overall survival, distinguishing it from lung cancers where it is expressed in tumor cells [13]. This evidence concerns the gene CD274 and lung carcinoma.